Anti-PEG Antibodies
Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery
A PBPK model that recapitulates anti-PEG antibody-mediated accelerated blood clearance of PEGylated nanomedicines in vivo
Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery
A PBPK model that recapitulates anti-PEG antibody-mediated accelerated blood clearance of PEGylated nanomedicines in vivo